US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Motif Bio plc

0.1050

0.0000

Volume:- -

Turnover:- -

Market Cap:50.97M

PE:-2.17

High:0.1050

Open:0.1050

Low:0.1050

Close:0.1050

52wk High:11.50

52wk Low:0.0750

Shares:485.35M

Float Shares:482.77M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0483

EPS(LYR):-0.0492

ROE:170.83%

ROA:-53.86%

PB:-5.71

PE(LYR):-2.14

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Motif Bio plc

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.motifbio.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is Iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus and multi-drug resistant streptococcus pneumoniae. Motif Bio plc was incorporated in 2014 and is based in London, the United Kingdom.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MTFB/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MTFB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTFB\",,,,,undefined,":{"symbol":"MTFB","market":"US","secType":"STK","nameCN":"Motif Bio plc","latestPrice":0.105011,"timestamp":1577826000000,"preClose":0.105011,"halted":4,"volume":0,"delay":0,"floatShares":482768055,"shares":485348166,"eps":-0.048292,"marketStatus":"Delisted","change":0,"latestTime":"12-19 19:55:29 EST","open":0.105011,"high":0.105011,"low":0.105011,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.048292,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1766192400000},"marketStatusCode":4,"adr":1,"adrRate":20,"listingDate":1479445200000,"exchange":"NASDAQ","adjPreClose":0.105011,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTFB\",,,,,undefined,":{"symbol":"MTFB","floatShares":482768055,"roa":"-53.86%","roe":"170.83%","lyrEps":-0.049151,"shares":485348166,"dividePrice":0,"high":0.105011,"amplitude":0,"preClose":0.105011,"low":0.105011,"week52Low":0.075,"pbRate":"-5.71","week52High":11.4999,"institutionHeld":0,"latestPrice":0.105011,"eps":-0.048292,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.048292,"open":0.105011},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MTFB\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MTFB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MTFB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.motifbio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0184},{"period":"1month","weight":0.0248},{"period":"3month","weight":0.0192},{"period":"6month","weight":0.1383},{"period":"1year","weight":0.1538},{"period":"ytd","weight":0.1542}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is Iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus and multi-drug resistant streptococcus pneumoniae. Motif Bio plc was incorporated in 2014 and is based in London, the United Kingdom.","exchange":"NASDAQ","name":"Motif Bio plc","nameEN":"Motif Bio plc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MTFB\",market:\"US\",,,undefined,":null}}